Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries

Hypertension Research

Volumn 33, Issue 8, 2010, Pages 857-866

  Baron Menguy, Céline ^a,b,c   Toutain, Bertrand ^a,b,c   Cousin, Maud ^d   Dumont, Odile ^a,b,c   Guihot, Anne Laure ^a,b,c   Vessières, Emilie ^a   Subra, Jean François ^c,d,e   Custaud, Marc Antoine ^a,b,c   Loufrani, Laurent ^a,b,c   Henrion, Daniel ^a,b,c,d  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e Team 12   (France)

Author keywords

angiotensin II; blood flow; endothelium; ERK1 2; vascular remodeling

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; APOCYNIN; CANDESARTAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PERINDOPRIL; SUPEROXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHESIS; IN VIVO STUDY; MESENTERIC ARTERY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR DISEASE; VASCULAR REMODELING;

EID: 77955359886     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.83     Document Type: Article

References (46)

1. Henrion D, Laher I, Laporte R, Bevan JA. Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur J Pharmacol 1992; 224: 13-20.
2. Ruiz E, Redondo S, Padilla E, Gordillo-Moscoso A, Salaices M, Balfagon G, Tejerina T. Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan. Eur J Pharmacol 2007; 567: 231-239.
3. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
4. Mulvany MJ. Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients. Metabolism 1998; 47: 20-23.
5. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155-164.
6. Levy BI. How to explain the differences between renin angiotensin system modulators. Am J Hypertens 2005; 18: 134S-141S.
7. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002; 17: 105-109.
8. De Mey JG, Schiffers PM, Hilgers RH, Sanders MM. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol 2005; 288: H1022-H1027.
9. Lehoux S, Tronc F, Tedgui A. Mechanisms of blood flow-induced vascular enlargement. Biorheology 2002; 39: 319-324.
10. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, Vanbavel E. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005; 96: 119-126.
11. Hilgers RH, Schiffers PM, Aartsen WM, Fazzi GE, Smits JF, De Mey JG. Tissue angiotensin-converting enzyme in imposed and physiological flow-related arterial remodeling in mice. Arterioscler Thromb Vasc Biol 2004; 24: 892-897.
12. Matrougui K, Loufrani L, Heymes C, Levy BI, Henrion D. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999; 34: 659-665.
13. Matrougui K, Levy BI, Henrion D. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol 2000; 130: 521-526.
14. Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R, Loufrani L, Henrion D. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007; 50: 96-102.
15. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005; 111: 1006-1011.
16. Cousin M, Custaud MA, Baron-Menguy C, Toutain B, Dumont O, Guihot AL, Vessieres E, Subra JF, Henrion D, Loufrani L. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 2010; 55: 109-115.
17. Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol 2007; 27: 317-324.
18. Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, Levy BI, Henrion D. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 2001; 103: 864-870.
19. Lawrenson L, Poole JG, Kim J, Brown C, Patel P, Richardson RS. Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol 2003; 285: H1023-H1031. (Pubitemid 37048156)
20. Pourageaud F, De Mey JG. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 1997; 273: H1699-H1706.
21. Belin de Chantemele EJ, Vessieres E, Dumont O, Guihot AL, Toutain B, Loufrani L, Henrion D. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009; 16: 391-402.
22. Loufrani L, Li Z, Levy BI, Paulin D, Henrion D. Excessive microvascular adaptation to changes in blood flow in mice lacking gene encoding for desmin. Arterioscler Thromb Vasc Biol 2002; 22: 1579-1584.
23. Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res 2002; 91: 1183-1189.
24. Gorny D, Loufrani L, Kubis N, Levy BI, Henrion D. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvasc Res 2002; 64: 127-134.
25. Dowell FJ, Henrion D, Benessiano J, Poitevin P, Levy B. Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J Hypertens 1996; 14: 177-182.
26. Dowell FJ, Henrion D, Duriez M, Michel JB. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol 1996; 117: 341-346.
27. Henrion D, Laher I, Bevan JA. Intraluminal flow increases vascular tone and 45Ca2+ influx in the rabbit facial vein. Circ Res 1992; 71: 339-345.
28. Iglarz M, Matrougui K, Levy BI, Henrion D. Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats. Cardiovasc Res 1998; 39: 657-664.
29. Belin de Chantemele EJ, Retailleau K, Pinaud F, Vessieres E, Bocquet A, Guihot AL, Lemaire B, Domenga V, Baufreton C, Loufrani L, Joutel A, Henrion D. Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb Vasc Biol 2008; 28: 2216-2224.
30. Loufrani L, Dubroca C, You D, Li Z, Levy B, Paulin D, Henrion D. Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin. Arterioscler Thromb Vasc Biol 2004; 24: 671-676.
31. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
32. Bouvet C, Belin de Chantemele E, Guihot AL, Vessieres E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P, Henrion D. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007; 50: 248-254.
33. Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res 2008; 77: 600-608.
34. Loufrani L, Retailleau K, Bocquet A, Dumont O, Danker K, Louis H, Lacolley P, Henrion D. Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. Am J Physiol Heart Circ Physiol 2008; 294: H1906-H1913.
35. Bagi Z, Toth E, Koller A, Kaley G. Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4). Am J Physiol Heart Circ Physiol 2004; 287: H626-H633.
36. Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Loufrani L, Henrion D. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries. Cardiovasc Res.
37. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol 1998; 274: H1301-H1307.
38. Higashi Y, Chayama K, Yoshizumi M. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress. Curr Med Chem Cardiovasc Hem tol Agents 2005; 3: 133-148.
39. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005; 7: 1302-1314.
40. Bakker EN, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, Vanbavel E. Blood flowdependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008; 78: 341-348.
41. Bakker EN, van der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002; 39: 12-20.
42. Henrion D, Dowell FJ, Levy BI, Michel JB. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension 1996; 28: 361-366.
43. Qiu HY, Henrion D, Levy BI. Alterations in flow-dependent vasomotor tone in spontaneously hypertensive rats. Hypertension 1994; 24: 474-479.
44. Mulvany MJ. Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy. Pharmacol Rep 2005; 57(Suppl): 144-150.
45. Khavandi K, Greenstein AS, Sonoyama K, Withers S, Price A, Malik RA, Heagerty AM. Myogenic tone and small artery remodelling: insight into diabetic nephropathy. Nephrol Dial Transplant 2009; 24: 361-369.
46. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31: 51-60.